• Biton V, Krauss G, Vasquez-Santana B, Bibbiani F, Mann A, Perdomo C, Narurkar M. (2011) A randomized, double-blind, placebo-controlled, parallel-group study of rufinamide as adjunctive therapy for refractory partial-onset seizures. Epilepsia52:234242.
  • Coppola G. (2011) Update on rufinamide in childhood epilepsy. Neuropsychiatr Dis Treat7:399407.
  • Coppola G, Grosso S, Franzoni E, Veggiotti P, Zamponi N, Parisi P, Spalice A, Habetswallner F, Fels A, Verrotti A, D’Aniello A, Mangano S, Balestri A, Curatolo P, Pascotto A. (2011) Rufinamide in refractory childhood epileptic encephalopathies other than Lennox–Gastaut syndrome. Eur J Neurol18:246251.
  • Gelisse P, Juntas-Morales R, Genton P, Hillaire-Buys D, Diaz O, Coubes P, Crespell A. (2007) Dramatic weight loss with levetiracetam. Epilepsia49:3083015.
  • Glauser T, Kluger G, Sachdeo R, Krauss G, Perdomo C, Arroyo S. (2008) Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome. Neurology70:19501958.
  • Härmark L, van Puijenbroek E, Straus S, van Grootheest K. (2011) Intensive monitoring of pregabalin: results from an observational, Web-based, prospective cohort study in the Netherlands using patients as a source of information. Drug Saf34:221231.
  • Wheless JW, Conry J, Krauss G, Mann A, LoPresti A, Narurkar M. (2009) Safety and tolerability of rufinamide in children with epilepsy: a pooled analysis of seven clinical studies. J Child Neurol24:15201525.